Unfortunately, no, but in terms of the valuation, it was important to find a solution that worked for all of us so that at least some simplicity and coherence were brought into the mechanism. It's related not to Canada's purchase price but rather to the equivalent that COVAX is needing to allocate per dose.
On March 21st, 2022. See this statement in context.